Efficacy of New Mindfulness-Based Swinging Technique Intervention: A Pilot Randomised Controlled Trial Among Women With Breast Cancer.

Ozan Bahcivan, Tania Estapé, Jose Gutierrez-Maldonado
Author Information
  1. Ozan Bahcivan: Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.
  2. Tania Estapé: FEFOC Foundation, Barcelona, Spain.
  3. Jose Gutierrez-Maldonado: Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.

Abstract

Objective: Combining 3rd-wave-therapies with Cognitive-Behavioural-Therapy (CBT) has increased in recent years. Usually these therapies require longer sessions which therefore increases the psychotherapy drop-out rate for cancer patients for multiple medical reasons. This inspired intervention of a shorter 20 min-long mindfulness-therapy (MBST) to be developed for Breast-Cancer-patients (BC).
Method: This pilot randomised controlled trial was to assess the immediate-outcome of the MBST-intervention for its efficacy for BC-patients by using the Pearson Chi-square test, Fisher-Freeman-Halton exact test, and McNemar test for categorical variables; Mann-Whitney U and Wilcoxon test for the continuous variables. The Emotion Thermometer, State Trait Anxiety Inventory, Hospital Anxiety and Depression Scale, Self-Efficacy for Managing Chronic Disease, and Beck's Hopelessness Scale were used for measuring the intervention outcomes. One hundred seventy-three BC patients were randomly assigned in two-groups (equal-mean-age,  = 0.417). Control-Group (CG,  = 82) received cognitive-disputation-technique a form-of-CBT, and Intervention-Group (IG,  = 74) received MBST. The directives are given to IG: psychoeducation about Mindfulness, and to imagine themselves swinging-in a peaceful environment. When the patients imagine their swing going up, they physically take a deep-breath, and when going down they physically release their breath, and this process is repeated.
Result: Outcomes post-treatment showed significant higher-improvement in IG in all the assessed-measurements, with large-effect-size: anxiety ( < 0,05,  = 0,67) and depression-levels ( < 0,05,  = 0,71); anxiety-trait ( < 0,05;  = 0,79) reduced, it increases self-efficacy for managing-disease ( < 0,05,  = 0,82) as-well-as hopefulness ( < 0,05,  = 0,61) and saturation-level measured by pulse-meter/oximeter ( < 0,05,  = 0,51).
Conclusion: MBST is an efficacious intervention to reduce psychotherapy session time for immediate relief from clinical anxiety and hopelessness as well as increase self-efficacy and improve tranquillity for BC-women. It may have a particular clinical significance for supporting patient's adherence to treatment. Although in this pilot sample MBST was found to be effective for short-term-outcome, its efficacy for longer-term-outcome should be examined in future trials. Additionally, breathing laps can be increased possibly for a greater result on rise of saturation levels of patients.

Keywords

References

  1. PLoS One. 2019 Jan 4;14(1):e0210111 [PMID: 30608969]
  2. Nat Rev Neurosci. 2015 Apr;16(4):213-25 [PMID: 25783612]
  3. Psychooncology. 2017 Jun;26(6):724-737 [PMID: 27412423]
  4. Clin Psychol Rev. 2013 Aug;33(6):763-71 [PMID: 23796855]
  5. J Cancer Surviv. 2019 Dec;13(6):943-955 [PMID: 31741250]
  6. J Consult Clin Psychol. 1974 Dec;42(6):861-5 [PMID: 4436473]
  7. Complement Ther Med. 2006 Jun;14(2):120-6 [PMID: 16765850]
  8. BMJ Open. 2018 Aug 23;8(8):e020702 [PMID: 30139895]
  9. Br J Cancer. 1999 Apr;80(1-2):262-8 [PMID: 10390006]
  10. J Exp Clin Cancer Res. 2008 Aug 29;27:32 [PMID: 18759983]
  11. Psychooncology. 2009 Dec;18(12):1261-72 [PMID: 19235193]
  12. Am Heart J. 2005 Jun;149(6):1137 [PMID: 15976804]
  13. J Clin Oncol. 2014 Feb 10;32(5):449-57 [PMID: 24395850]
  14. J Clin Oncol. 2012 Apr 10;30(11):1154-9 [PMID: 22412134]
  15. Breast J. 2018 Mar;24(2):167-175 [PMID: 28845551]
  16. Psychiatr Danub. 2017 Dec;29(4):451-458 [PMID: 29197202]
  17. Psychooncology. 2019 Jul;28(7):1394-1407 [PMID: 31077475]
  18. Med Hypotheses. 2018 Dec;121:42-43 [PMID: 30396486]
  19. Neurosci Biobehav Rev. 2012 Feb;36(2):747-56 [PMID: 22178086]
  20. Br J Health Psychol. 2016 Nov;21(4):859-880 [PMID: 27238732]
  21. Eur J Cancer Care (Engl). 2019 May;28(3):e13010 [PMID: 30740814]
  22. Stress Health. 2021 Feb;37(1):3-18 [PMID: 32720741]
  23. Nurs Res. 2009 Jan-Feb;58(1):32-41 [PMID: 19092553]
  24. CA Cancer J Clin. 2019 Jan;69(1):7-34 [PMID: 30620402]
  25. Tijdschr Psychiatr. 2019;61(9):605-616 [PMID: 31560780]
  26. Psychol Med. 2017 Apr;47(6):990-999 [PMID: 28031068]
  27. BMJ. 2016 Oct 24;355:i5239 [PMID: 27777223]
  28. J Altern Complement Med. 2018 Sep/Oct;24(9-10):902-909 [PMID: 30247957]
  29. Cancer. 2021 May 1;127(9):1377-1386 [PMID: 33332582]
  30. Iran Red Crescent Med J. 2015 Nov 28;17(11):e31277 [PMID: 26734485]
  31. Integr Cancer Ther. 2020 Jan-Dec;19:1534735419890682 [PMID: 31957499]
  32. J Consult Clin Psychol. 2012 Oct;80(5):750-65 [PMID: 22563639]
  33. Psychooncology. 2010 Feb;19(2):125-33 [PMID: 19296462]
  34. Prof Psychol Res Pr. 2022 Apr;53(2):109-115 [PMID: 37694263]
  35. Front Psychol. 2019 Jan 31;10:162 [PMID: 30766505]
  36. J Palliat Med. 2016 Sep;19(9):917-24 [PMID: 27110900]
  37. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 [PMID: 6880820]
  38. J Clin Nurs. 2010 Apr;19(7-8):1073-83 [PMID: 20492052]
  39. J Natl Cancer Inst. 2001 Jun 6;93(11):810-23 [PMID: 11390531]
  40. Trials. 2016 Apr 22;17(1):209 [PMID: 27101823]
  41. Soc Cogn Affect Neurosci. 2014 Jun;9(6):776-85 [PMID: 23563850]
  42. Complement Ther Clin Pract. 2020 Aug;40:101213 [PMID: 32891289]
  43. Clin J Oncol Nurs. 2019 Oct 1;23(5):E87-E92 [PMID: 31538976]
  44. Turk J Med Sci. 2020 Apr 27;50(5):1254-1261 [PMID: 32336077]
  45. Psychooncology. 2009 Jun;18(6):571-9 [PMID: 19023879]
  46. Cancer Med. 2017 May;6(5):1108-1122 [PMID: 28421677]
  47. Qual Life Res. 2010 Aug;19(6):827-36 [PMID: 20401551]
  48. Breast Cancer Res Treat. 2007 Jul;104(1):39-46 [PMID: 17009107]
  49. Rural Remote Health. 2014;14:2561 [PMID: 24579719]
  50. Integr Cancer Ther. 2020 Jan-Dec;19:1534735419893766 [PMID: 32009481]
  51. Int J Behav Med. 2012 Dec;19(4):535-42 [PMID: 21931958]
  52. Brain Behav Immun. 2008 Aug;22(6):969-81 [PMID: 18359186]
  53. Psychother Psychosom. 2007;76(6):332-8 [PMID: 17917468]
  54. Psychooncology. 2006 May;15(5):363-73 [PMID: 16288447]
  55. World Psychiatry. 2017 Oct;16(3):245-246 [PMID: 28941087]
  56. Integr Cancer Ther. 2012 Jun;11(2):101-10 [PMID: 21715370]
  57. Cochrane Database Syst Rev. 2010 Sep 8;(9): [PMID: 25067906]
  58. Front Hum Neurosci. 2012 Nov 01;6:292 [PMID: 23125828]
  59. Eff Clin Pract. 2001 Nov-Dec;4(6):256-62 [PMID: 11769298]
  60. Int J Behav Med. 2005;12(4):278-85 [PMID: 16262547]
  61. Patient Educ Couns. 2003 Jun;50(2):179-86 [PMID: 12781933]
  62. CA Cancer J Clin. 2018 Nov;68(6):394-424 [PMID: 30207593]
  63. Am J Health Promot. 2010 Jul-Aug;24(6):e1-e25 [PMID: 20594090]
  64. Cancer Biol Med. 2014 Jun;11(2):101-15 [PMID: 25009752]
  65. Clin J Oncol Nurs. 2013 Dec;17(6):654-8 [PMID: 24305486]
  66. Acta Oncol. 2020 Apr;59(4):444-452 [PMID: 32000559]
  67. Am J Hosp Palliat Care. 2019 Jun;36(6):478-484 [PMID: 30453747]
  68. Lancet Oncol. 2011 Feb;12(2):160-74 [PMID: 21251875]
  69. Iran J Med Sci. 2022 Mar;47(2):95-106 [PMID: 35291438]
  70. Evid Based Complement Alternat Med. 2015;2015:270876 [PMID: 26347018]
  71. Psychooncology. 2019 Sep;28(9):1781-1790 [PMID: 31206917]
  72. Stress Health. 2012 Dec;28(5):397-407 [PMID: 23129559]
  73. Complement Ther Clin Pract. 2018 Feb;30:68-78 [PMID: 29389483]
  74. Explore (NY). 2018 Mar - Apr;14(2):137-143 [PMID: 29506956]

Word Cloud

Created with Highcharts 10.0.0 = 0< 005patientsMBSTtestinterventionanxietyself-efficacyincreasedincreasespsychotherapycancerBCpilotefficacyvariablesAnxietyScalereceivedIGimaginegoingphysicallyclinicaladherencetreatmentObjective:Combining3rd-wave-therapiesCognitive-Behavioural-TherapyCBTrecentyearsUsuallytherapiesrequirelongersessionsthereforedrop-outratemultiplemedicalreasonsinspiredshorter20 min-longmindfulness-therapydevelopedBreast-Cancer-patientsMethod:randomisedcontrolledtrialassessimmediate-outcomeMBST-interventionBC-patientsusingPearsonChi-squareFisher-Freeman-HaltonexactMcNemarcategoricalMann-WhitneyUWilcoxoncontinuousEmotionThermometerStateTraitInventoryHospitalDepressionSelf-EfficacyManagingChronicDiseaseBeck'sHopelessnessusedmeasuringoutcomesOnehundredseventy-threerandomlyassignedtwo-groupsequal-mean-age417Control-GroupCG = 82cognitive-disputation-techniqueform-of-CBTIntervention-Group = 74directivesgivenIG:psychoeducationMindfulnessswinging-inpeacefulenvironmentswingtakedeep-breathreleasebreathprocessrepeatedResult:Outcomespost-treatmentshowedsignificanthigher-improvementassessed-measurementslarge-effect-size:67depression-levels71anxiety-trait79reducedmanaging-disease82as-well-ashopefulness61saturation-levelmeasuredpulse-meter/oximeter51Conclusion:efficaciousreducesessiontimeimmediatereliefhopelessnesswellincreaseimprovetranquillityBC-womenmayparticularsignificancesupportingpatient'sAlthoughsamplefoundeffectiveshort-term-outcomelonger-term-outcomeexaminedfuturetrialsAdditionallybreathinglapscanpossiblygreaterresultrisesaturationlevelsEfficacyNewMindfulness-BasedSwingingTechniqueIntervention:PilotRandomisedControlledTrialAmongWomenBreastCancerMBST®breastmindfulness

Similar Articles

Cited By